Page last updated: 2024-11-03

prazosin and Cancer of the Thyroid

prazosin has been researched along with Cancer of the Thyroid in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuchs, R1
Schwach, G1
Stracke, A1
Meier-Allard, N1
Absenger, M1
Ingolic, E1
Haas, HS1
Pfragner, R1
Sadjak, A1
Nakamura, S1
Ishiyama, M1
Sugimoto, M1
Kosaka, J1
Watanabe, H1
Horiya, Y1
Hara, S1
Shima, H1

Other Studies

2 other studies available for prazosin and Cancer of the Thyroid

ArticleYear
The anti-hypertensive drug prazosin induces apoptosis in the medullary thyroid carcinoma cell line TT.
    Anticancer research, 2015, Volume: 35, Issue:1

    Topics: Antihypertensive Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Medullary; Cell Line, Tumor; D

2015
A case of extraadrenal pheochromocytoma with papillary thyroid carcinoma.
    Endocrinologia japonica, 1991, Volume: 38, Issue:4

    Topics: Abdominal Neoplasms; Carcinoma, Papillary; Catecholamines; Female; Humans; Hypertension; Magnetic Re

1991